M
Madrigal Pharmaceuticals D
D
MDGL
298.20
USD
-2.26
(-0.75%)
مغلق
حجم التداول
3,803
الربح لكل سهم
-17
العائد الربحي
-
P/E
-17
حجم السوق
6,621,018,692
العنوان: Madrigal Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.